Skip to main content
Signal8

DANIELS RONALD J

SEC insider (Form 3/4/5 filer). CIK 0001164475. Director at BridgeBio Pharma, Inc. (BBIO). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PALO ALTO, CA.

Companies DANIELS RONALD J has filed insider reports for

  • BridgeBio Pharma, Inc. (BBIO): Director
DANIELS RONALD J profile photo

DANIELS RONALD J

CIK: 0001164475

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BridgeBio Pharma, Inc. logo
BBIO

BridgeBio Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jun 22, 2026
    Award
    Direct
    4K shares-
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Nov 6, 2025
    Exercise
    Direct
    61K shares at avg. $34.65$2.1M
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Nov 6, 2025
    Sale
    Direct
    61K shares at avg. $63.72$3.9M
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jun 20, 2025
    Award
    Direct
    6.6K shares-

1-4 of 4